The US Patent office has recently (May 28) issued a patent to the French biologist Emmanuelle Charpentier and US colleague Jennifer Doudna covering the methods of modulating DNA transcription with the much-vaunted but controversial CRISPR-Cas9 system. The patent (No. 10,301,651) which included Unive...
labnews.co.uk